Tiziana Life Sci - Share Talk

Tiziana Life Sci PLC (LON:TILS) Phase 2a Clinical Data

abm September 4, 2019

Tiziana Life Sciences Reports Positive Phase 2a Clinical Data Exhibiting Positive Clinical Activity with Milciclib Monotherapy in Advanced Sorafenib-refractory or -intolerant Patients with Unresectable or Metastatic Hepatocellular Carcinoma

Share Talk Weekly Stock Market News, 27th July 2019

abm July 27, 2019

Share Talk was back in London this week on business and we held a few meeting with listed companies, some of the market sectors are currently struggling in the small-cap

Tiziana Life Sci PLC (NASDAQ:TLSA LON:TILS) Dr Kunwar Shailubhai, CEO & CSO

abm July 22, 2019

Tiziana Reports Phase 2a Clinical Data with Milciclib Monotherapy in Sorafenib-refractory or -intolerant patients with unresectable or metastatic Hepatocellular Carcinoma.

Tag: Tiziana Life Sci

Tiziana Life Sci PLC (LON:TILS) Phase 2a Clinical Data

Tiziana Life Sci PLC (NASDAQ:TLSA LON:TILS) Dr Kunwar Shailubhai, CEO & CSO

Add Share Talk to your Homescreen!